SMC Ltd. is proud to be among 4 finalists in the central region for the 2017 Team Massachusetts Economic Impact Awards as chosen by MassEcon. Finalists were selected based on their job growth, facility expansion, investment, and community involvement. “We are honored to be chosen as a finalist for the MassEcon 2017 award. SMC Ltd. is committed to the communities and places where we live and work and excited by the growth opportunities Massachusetts provides.” Brian Payson – VP and General Manager SMC Ltd. Finalists in each of the five regions will be announced in October 2017. To read more about the award, visit the MassEcon website.
Due to continued growth, SMC is looking for career-minded individuals for all of our worldwide locations. SMC provides a fast-paced environment with career growth opportunities. We’re committed to advancing employees’ careers by providing hands-on training, educational assistance, and internal growth opportunities. Click here for a list of our latest careers.
Members of SMC Ltd. will be attending the MD&M East show in New York, NY June 13-15, 2017. If you or someone you know is attending and would like to learn about manufacturing scale-up, or finished device manufacturing, contact us to connect for a meeting.
Join SMC Ltd. and Oval Medical during RDD Europe April 25-28 to discuss the latest trends in Respiratory Drug Delivery. Members of our team will be displaying examples of diverse device solutions. If you would like to learn about design, manufacturing scale-up, or production of combination products please contact us to set-up a meeting, or stop by our booth in the exhibit hall.
“Oval’s autoinjectors offer pharma companies clear differentiation from their competitors through innovative design and offer benefits including accurate dosing with high viscosity formulations and improved stability for biologics within small, intuitive-to-use devices for patients,” Read how SMC and Oval are working together on the next generation of Autoinjectors. Read the full article here: http://www.qmed.com/mpmn/medtechpulse/new-autoinjector-options-emergency-use-drugs?cid=nl.x.qmed02.edt.aud.qmed.201701242
SMC Ltd. and Oval Medical Technologies will be attending the DDP show in Palm Beach Gardens, FL February 7-9, 2017. If you, or someone you know, will be attending and would like to learn about the next generation of auto injectors, manufacturing scale-up, or production of combination products please let us know and we can connect you for a meeting.
Stop by the SMC Ltd. booth #2801 to meet with our Business Development Managers who can show you how SMC is partnering with top medical OEM’s to bring solutions to their finished devices, combination products, and connected devices.
SMC Ltd. will be exhibiting at Pharmapack Europe in Paris, France. Visit us at booth #L24 to meet members of our Oval Medical Technologies team and learn about the next generation of auto injectors, manufacturing scale-up, and production of combination products.
SMC Ltd. announced today that it has acquired Oval Medical Technologies Ltd., a specialty pharmaceutical device company developing next generation autoinjectors based in Cambridge, UK. Oval’s autoinjector platforms address the unmet needs in the self-injection market utilizing both cyclic olefin plastic and glass primary drug containers. Their autoinjectors deliver both non-viscous and viscous drugs. The convenient design of the autoinjector provides patients with an ease-of-use solution for fast and simple two-step administration in emergency and non-emergency environments. This unique platform is available to pharmaceutical companies for their drug delivery systems. Click here to read the full press release.
SMC’s drug delivery team has the experience of handling and integrating pharmaceutical drugs into the customized delivery device for final combination product assembly with customer and regulatory approved product labeling, patient instructions for use, and packaging. To learn more about our Drug Delivery capabilities click here.